Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02916927 · ClinicalTrials.gov registry record · Phase 4
Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department
A Phase 4 study, sponsored by Alameda Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT02916927: Completed Phase 4 study, sponsored by Alameda Health System.
NCT02916927 is a Phase 4 study that has completed, run by Alameda Health System. The registered enrollment target is 62 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02916927, a Phase 4 study, has completed, sponsored by Alameda Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
Objective: The purpose of this study is to determine if administering ketamine as an intravenous (IV) infusion over 15 minutes, as compared to an IV push, will decrease adverse drug reactions without attenuating its analgesic effects. Study design: prospective, randomized, controlled, double-blind trial.
Primary Outcome
The difference in percentage of participants endorsing side effects between each arm of the study over 60 minutes.
Interventions
- DRUG Ketamine IV Infusion
- DRUG Ketamine IV push
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
What the finished NCT02916927 record still lists
NCT02916927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Ketamine IV Infusion is the first listed.
NCT02916927 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02916927 about?
NCT02916927 is a clinical study titled "Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department". Objective: The purpose of this study is to determine if administering ketamine as an intravenous (IV) infusion over 15 minutes, as compared to an IV push, will decrease adverse drug reactions without attenuating its analgesic effects. Study design: prospective, randomized, controlled, double-blind ...
What is the current status of trial NCT02916927?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2016-09. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02916927?
The interventions under investigation include: Ketamine IV Infusion (DRUG), Ketamine IV push (DRUG).
Who is sponsoring clinical trial NCT02916927?
This trial is sponsored by Alameda Health System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02916927's enrollment target sits among peer trials
62 1110th of 2000 higher than 882 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia